Pharmacokinetic and tissue distribution mechanism of mouse recombinant heat shock protein 70 in mice

Pharmaceutical Research

Volumn 22, Issue 3, 2005, Pages 419-426

  Takemoto, Seiji ^a   Nishikawa, Makiya ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Delivery; Heat shock protein 70; Hepatocytes; Pharmacokinetics; Uptake; Vaccine

Indexed keywords

INDIUM 111; RECOMBINANT HEAT SHOCK PROTEIN 70; RECOMBINANT PROTEIN; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL LABELING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ELIMINATION; DRUG INHIBITION; DRUG UPTAKE; IN VIVO STUDY; INJECTION SITE; LIVER CELL; LIVER MICROSOME METABOLISM; LYMPH NODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEPATOCYTES; HSP70 HEAT-SHOCK PROTEINS; MALE; MICE; RECOMBINANT PROTEINS; TISSUE DISTRIBUTION;

EID: 17644391384     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-004-1880-0     Document Type: Article

References (29)

1. B. Bukau and A. L. Horwich. The Hsp70 and Hsp60 chaperone machines. Cell 92:351-366 (1998).
2. J. E. Rothman. Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells. Cell 59:591-601 (1989).
3. F. U. Hartl. Molecular chaperones in cellular protein folding. Nature 381:571-579 (1996).
4. Y. Moroi, M. Mayhew, J. Trcka, M. H. Hoe, Y. Takechi, F. U. Hartl, J. E. Rothman, and A. N. Houghton. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc. Natl. Acad. Sci. USA 97:3485-3490 (2000).
5. H. Udono and P. K. Srivastava. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70. J. Immunol. 152:5398-5403 (1994).
6. C. Gross, D. Hansch, R. Gastpar, and G. Multhoff. Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94. Biol. Chem. 384:267-279 (2003).
7. P. Srivastava. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu. Rev. Immunol. 20:395-425 (2002).
8. S. Somersan, M. Larsson, J. F. Fonteneau, S. Basu, P. Srivastava, and N. Bhardwaj. Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells. J. Immunol. 167:4844-4852 (2001).
9. S. Basu, R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 12:1539-1546 (2000).
10. J. Herz and D. K. Strickland. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108:779-784 (2001).
11. R. J. Binder, D. K. Han, and P. K. Srivastava. CD91: a receptor for heat shock protein gp96. Nat. Immunol. 1:151-155 (2000).
12. Y. Delneste, G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, and P. Jeannin. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353-362 (2002).
13. G. Draude, N. Hrboticky, and R. L. Lorenz. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem. Pharmacol. 57:383-386 (1999).
14. C. T. Chu and S. V. Pizzo. Receptor-mediated antigen delivery into macrophages. Complexing antigen to alpha 2-macroglobulin enhances presentation to T cells. J. Immunol. 150:48-58 (1993).
15. D. J. Hnatowich, W. W. Layne, and R. L. Childs. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33:327-332 (1982).
16. J. R. Duncan and M. J. Welch. Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J. Nucl. Med. 34:1728-1738 (1993).
17. Y. Arano, T. Mukai, T. Uezono, K. Wakisaka, H. Motonari, H. Akizawa, Y. Taoka, and A. Yokoyama. A biological method to evaluate bifunctional chelating agents to label antibodies with metallic radionuclides. J. Nucl. Med. 35:890-898 (1994).
18. R. Blomhoff, H. K. Blomhoff, H. Tolleshaug, T. B. Christensen, and T. Berg. Uptake and degradation of bovine testes beta-galactosidase by parenchymal and nonparenchymal rat liver cells. Int. J. Biochem. 17:1321-1328 (1985).
19. K. Yamaoka, Y. Tanigawara, T. Nakagawa, and T. Uno. A pharmacokinetic analysis program (multi) for microcomputer. J. Pharmacobiodyn. 4:879-885 (1981).
20. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida. Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(L-lysine) complexes by controlling their physicochemical properties. J. Pharmacol. Exp. Ther. 287:408-415 (1998).
21. P. K. Srivastava. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods 12:165-171 (1997).
22. M. Graner, A. Raymond, E. Akporiaye, and E. Katsanis. Tumor-derived multiple chaperone enrichment by free-solution isoelectric focusing yields potent antitumor vaccines. Cancer Immunol. Immunother. 49:476-484 (2000).
23. R. Abraham, N. Singh, A. Mukhopadhyay, S. K. Basu, V. Bal, and S. Rath. Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages. J. Immunol. 154:1-8 (1995).
24. S. Basu, R. J. Binder, T. Ramalingam, and P. K. Srivastava. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-313 (2001).
25. Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, and Y. Takakura. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301:467-477 (2002).
26. D. K. Strickland, J. D. Ashcom, S. Williams, W. H. Burgess, M. Migliorini, and W. S. Argraves. Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol Chem. 265:17401-17404 (1990).
27. R. W. Jansen, P. Olinga, G. Harms, and D. K. Meijer. Pharmacokinetic analysis and cellular distribution of the anti-HIV compound succinylated human serum albumin (Suc-HSA) in vivo and in the isolated perfused rat liver. Pharm. Res. 10:1611-1614 (1993).
28. M. E. Kuipers, P. J. Swart, M. Schutten, C. Smit, J. H. Proost, A. D. Osterhaus, and D. K. Meijer. Pharmacokinetics and anti-HIV-1 efficacy of negatively charged human serum albumins in mice. Antiviral Res. 33:99-108 (1997).
29. Y. Yamasaki, K. Sumimoto, M. Nishikawa, F. Yamashita, K. Yamaoka, M. Hashida, and Y. Takakura. Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors. J. Pharmacol. Exp. Ther. 301:467-477 (2002).